|
|
|
|
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Abbott's ARCHITECT human epididymis protein 4 (HE4) assay submitted for 510(k) clearance Buzz up!Companies: Related Quotes {'s' : 'abt','k' : 'c10,l10,p20,t10','o' : '','j' : ''} ABBOTT PARK, Ill., Feb! 8 /PRNewswire-FirstCall/ -- A new diagnostic tool...
|
|
|
Single gene mutation induces endometrial cancer
DALLAS Feb.10, 2010 A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study. The finding suggests that eventually it might be...
|
|
|
Single gene mutation induces endometrial cancer
A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study.The finding suggests that eventually it might be possible to screen...
|
|
|
Single gene mutation can cause endometrial cancer
n can cause endometrial cancer In an animal study, researchers at UT Southwestern Medical Center have found that a mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy.The researchers said that the...
|
|
|
Single gene mutation can cause endometrial cancer
In an animal study, researchers at UT Southwestern Medical Center have found that a mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy.The researchers said that the finding suggests that eventually it...
|
|
|
Researchers find that mutation in single gene can cause endometrial cancer
A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study.The finding suggests that eventually it might be possible to screen...
|
|
|
Cancer expert Carolyn Runowicz gives address at HOW luncheon at Flagler
One of the country's leading cancer clinicians was the keynote speaker at the annual fundraiser for Hearing the Ovarian Cancer Whisper.The Time is of the Essence luncheon took place Jan. 25 at the Flagler Museum and featured a keynote...
|
|
|
Life-changing cancer battle
A mum who beat cancer is on the road to business success as she fulfils a lifelong dream.When Ruth Foster was told she had a rare form of ovarian cancer five years ago, she decided to take control of her life and open her own business.The...
|
|
|
Ovary Removal Following Cancer Diagnosis Improves Survival Rate
Women who have recently been diagnosed with ovarian cancer or who are at a high risk for developing the disease may benefit from having their ovaries removed, said a gynecologic oncologist at.For patients with a new diagnosis of ovarian ...
|
|
|
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Abbott's ARCHITECT human epididymis protein 4 (HE4) assay submitted for 510(k) clearance ABBOTT PARK, Ill., Feb.8 (HSMN NewsFeed) -- A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon...
|
|
|
Abbott Submits New Automated Ovarian Cancer Test For U.S. Approval
A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States.Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or...
|
|
|
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
ABBOTT PARK, Ill., Feb.8 /PRNewswire-FirstCall/ -- A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States. Abbott's ARCHITECT HE4 assay uses a simple...
|
|
|
Abbott Submits New Automated Ovarian Cancer Test For U.S. Approval
Abbott's ARCHITECT human epididymis protein 4 (HE4) assay submitted for 510(k) clearance Abbott Park, IL/PRNewswire-FirstCall/ - A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be...
|
|
|
Abbott Submits New Automated Ovarian Cancer Test for US Approval
A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States.Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or...
|
|
|
Single Gene Mutation Induces Endometrial Cancer
Source: UT Southwestern Medical Center Newswise A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study.The finding suggests...
|
|
|
Single Gene Mutation Induces Endometrial Cancer
Newswise - A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study.The finding suggests that eventually it might be possible to...
|
|
|
Abbott seeks U.S. approval for HE4 assay to monitor recurrence/progression of epithelial ovarian cancer
A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States.Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or...
|
|
|
Single gene mutation induces endometrial cancer
DALLAS Feb.10, 2010 A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study. The finding suggests that eventually it might be...
|
|
|
An Early Warning System for Cancer
Autoantibodies could alert doctors to cancer development.A new screening tool developed by scientists in Denmark may help detect the earliest stages of cancer by taking advantage of the body's own defenses. The researchers constructed a...
|
|
|
Abbott seeks FDA nod on ovarian cancer test
ABBOTT PARK -- Abbott Laboratories has asked the Food and Drug Administration for pre-market approval for a new automated test for ovarian cancer, the company said Monday.Abbott's Architect HE4 diagnostic assay uses a simple blood test to help in...
|
|
|
Women's genes and heritage reveal cancer risk
Would you want to know you were a greater risk than the average woman of developing breast or ovarian cancer?Two thousand women in Ontario did? Find out what their genetic predisposition exposed. Updated: Published: 2010-02-01 14:15 Heather...
|
|
|
DxS Negotiates PI3K License from JHU to Develop Companion Diagnostics
Cancer GEN News Highlights GEN News Highlights QiagensDxS subsidiary negotiated an exclusive global license to the Johns Hopkins University PI3K biomarker patent for use in the development of PCR-based companion diagnostics for cancer therapies.
|
|
|
Medical News: Abbott Submits New Automated Ovarian Cancer Test For U.S. Approval
A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States.Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or...
|
|
|
Ovarian Cancer Drug Trial
Hematology & Oncology Specialists (4228 Houma Blvd., Metairie, 883-2960) is enrolling patients in a global clinical trial to evaluate an investigational treatment for women whose platinum-sensitive ovarian cancer has recurred.Patients...
|
|
|
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States.Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval.
|
